Targets in the New Era

          TNBC subsets

          Her2 additional targets

          PI3K-Akt-mTOR inhibitors

          P53 restoration

          MultiGene/Next Gen Sequencing Panels

          News: Immunotherapy is back?


BRCA and BRCA-like
Breast Cancers

          Triple negative (esp BRCA1)

          Susceptible to DNA damaging agents like cisplatin

        BRCA deficient cells can’t repair double strand DNA breaks very well leading to death


Project details

Tags: Pathway Targeted Therapy

Related projects

Vivamus molestie gravida turpis